Syros Pharmaceuticals Other Current Liabilities

Syros Pharmaceuticals (SYRS) currently reports a other current liabilities of $16M as of September 2024. That compares with $21M in the prior-year period — down 24.8% year over year. Use the charts on this page to explore Syros Pharmaceuticals's other current liabilities history and peer comparisons.

Syros Pharmaceuticals's other current liabilities decreased from $21M to $16M — a 24.8% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Syros Pharmaceuticals reported $16M in other current liabilities as of September 2024. That compares with $21M in the prior-year period — down 24.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $16M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Syros Pharmaceuticals, and consider following SYRS for alerts when major investors trade the stock.

Syros Pharmaceuticals is classified in the Healthcare sector. On other current liabilities, it currently shows $16M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SYRS with unrelated industries.